Avodart 0.5 mg

Description

Avodart belongs to a class of medications known as 5-alpha reductase inhibitors. It works by blocking the production of a hormone called dihydrotestosterone (DHT), which is primarily responsible for the enlargement of the prostate gland. By lowering DHT levels, Avodart helps to shrink the enlarged prostate over time, leading to significant improvements in urinary symptoms such as difficulty starting urination, weak stream, and the need to urinate frequently or urgently. This targeted approach not only provides relief from daily discomfort but also helps in managing the progression of BPH effectively.

Quality Formulation by GSK Manufactured by GlaxoSmithKline (GSK), these 0.5 mg soft capsules are designed for easy swallowing and consistent absorption. Each pack contains 30 capsules, typically providing a full month’s supply for a once-daily regimen. Because BPH is a chronic condition, Avodart is intended for long-term use to achieve and maintain its therapeutic benefits. Consistent use as prescribed by a healthcare professional is key to seeing a reduction in prostate volume and a decrease in the long-term risk of requiring surgery. It is a cornerstone treatment for men looking to regain comfort and improve their quality of life through medically-backed hormone regulation.